Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis
Language English Country United States Media print
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R01 CA067941
NCI NIH HHS - United States
U01 HG004438
NHGRI NIH HHS - United States
U01 HG004446
NHGRI NIH HHS - United States
K05 CA154337
NCI NIH HHS - United States
U01 CA164930
NCI NIH HHS - United States
P30 CA076292
NCI NIH HHS - United States
HHSN268201100003I
NHLBI NIH HHS - United States
P01 CA196569
NCI NIH HHS - United States
U01 CA067941
NCI NIH HHS - United States
R01 CA059045
NCI NIH HHS - United States
HHSN268201100001I
NHLBI NIH HHS - United States
R01 CA197350
NCI NIH HHS - United States
R01 CA076366
NCI NIH HHS - United States
R35 CA197735
NCI NIH HHS - United States
U10 CA037429
NCI NIH HHS - United States
U01 CA182883
NCI NIH HHS - United States
R01 CA072520
NCI NIH HHS - United States
P01 CA087969
NCI NIH HHS - United States
P30 CA015704
NCI NIH HHS - United States
P30 DK043351
NIDDK NIH HHS - United States
HHSN268201100004I
NHLBI NIH HHS - United States
P30 CA006973
NCI NIH HHS - United States
Z01 CP010200
Intramural NIH HHS - United States
P01 CA055075
NCI NIH HHS - United States
S10 OD028685
NIH HHS - United States
R01 CA151993
NCI NIH HHS - United States
HHSN268201100046C
NHLBI NIH HHS - United States
P30 DK034987
NIDDK NIH HHS - United States
R01 CA048998
NCI NIH HHS - United States
U01 CA137088
NCI NIH HHS - United States
R01 CA189184
NCI NIH HHS - United States
U01 CA167552
NCI NIH HHS - United States
HHSN268201100003C
WHI NIH HHS - United States
U01 CA261961
NCI NIH HHS - United States
U24 CA074794
NCI NIH HHS - United States
R01 CA263776
NCI NIH HHS - United States
R01 CA066635
NCI NIH HHS - United States
R21 CA191312
NCI NIH HHS - United States
U01 CA206110
NCI NIH HHS - United States
R01 CA137178
NCI NIH HHS - United States
U01 CA074794
NCI NIH HHS - United States
HHSN268201200008C
NHLBI NIH HHS - United States
R01 CA242218
NCI NIH HHS - United States
P30 CA008748
NCI NIH HHS - United States
U01 CA167551
NCI NIH HHS - United States
P30 CA014089
NCI NIH HHS - United States
R01 CA081488
NCI NIH HHS - United States
HHSN271201100004C
NIA NIH HHS - United States
R01 CA201407
NCI NIH HHS - United States
R01 CA063464
NCI NIH HHS - United States
P01 CA033619
NCI NIH HHS - United States
U01 CA086308
NCI NIH HHS - United States
UM1 CA186107
NCI NIH HHS - United States
HHSN268201100002C
WHI NIH HHS - United States
R01 CA207371
NCI NIH HHS - United States
R03 CA153323
NCI NIH HHS - United States
R01 CA042182
NCI NIH HHS - United States
R01 CA054281
NCI NIH HHS - United States
T32 ES013678
NIEHS NIH HHS - United States
R01 CA136726
NCI NIH HHS - United States
P30 CA016058
NCI NIH HHS - United States
UM1 CA167552
NCI NIH HHS - United States
K05 CA152715
NCI NIH HHS - United States
U01 CA122839
NCI NIH HHS - United States
HHSN268201100002I
NHLBI NIH HHS - United States
U01 CA074783
NCI NIH HHS - United States
U01 CA084968
NCI NIH HHS - United States
KL2 TR000421
NCATS NIH HHS - United States
UM1 CA182883
NCI NIH HHS - United States
HHSN268201200008I
NHLBI NIH HHS - United States
R37 CA054281
NCI NIH HHS - United States
HHSN268201100001C
WHI NIH HHS - United States
HHSN268201100004C
WHI NIH HHS - United States
R01 CA097325
NCI NIH HHS - United States
HHSN268201700006C
NHLBI NIH HHS - United States
U19 CA148107
NCI NIH HHS - United States
U01 AG018033
NIA NIH HHS - United States
PubMed
36512731
PubMed Central
PMC9905300
DOI
10.1158/1055-9965.epi-22-0861
PII: 711646
Knihovny.cz E-resources
- MeSH
- Butyrates * analysis metabolism MeSH
- Feces * chemistry microbiology MeSH
- Colorectal Neoplasms * epidemiology genetics metabolism MeSH
- Fatty Acids, Volatile analysis genetics metabolism MeSH
- Humans MeSH
- Mendelian Randomization Analysis MeSH
- Propionates * analysis metabolism MeSH
- Risk MeSH
- Gastrointestinal Microbiome * genetics physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Geographicals
- Europe epidemiology MeSH
- Names of Substances
- Butyrates * MeSH
- Fatty Acids, Volatile MeSH
- Propionates * MeSH
BACKGROUND: Mechanistic data indicate the benefit of short-chain fatty acids (SCFA) produced by gut microbial fermentation of fiber on colorectal cancer, but direct epidemiologic evidence is limited. A recent study identified SNPs for two SCFA traits (fecal propionate and butyrate-producing microbiome pathway PWY-5022) in Europeans and showed metabolic benefits. METHODS: We conducted a two-sample Mendelian randomization analysis of the genetic instruments for the two SCFA traits (three SNPs for fecal propionate and nine for PWY-5022) in relation to colorectal cancer risk in three large European genetic consortia of 58,131 colorectal cancer cases and 67,347 controls. We estimated the risk of overall colorectal cancer and conducted subgroup analyses by sex, age, and anatomic subsites of colorectal cancer. RESULTS: We did not observe strong evidence for an association of the genetic predictors for fecal propionate levels and the abundance of PWY-5022 with the risk of overall colorectal cancer, colorectal cancer by sex, or early-onset colorectal cancer (diagnosed at <50 years), with no evidence of heterogeneity or pleiotropy. When assessed by tumor subsites, we found weak evidence for an association between PWY-5022 and risk of rectal cancer (OR per 1-SD, 0.95; 95% confidence intervals, 0.91-0.99; P = 0.03) but it did not surpass multiple testing of subgroup analysis. CONCLUSIONS: Genetic instruments for fecal propionate levels and the abundance of PWY-5022 were not associated with colorectal cancer risk. IMPACT: Fecal propionate and PWY-5022 may not have a substantial influence on colorectal cancer risk. Future research is warranted to comprehensively investigate the effects of SCFA-producing bacteria and SCFAs on colorectal cancer risk.
Biomedical Centre Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Center for Cancer Research Medical University of Vienna Vienna Austria
Consortium for Biomedical Research in Epidemiology and Public Health Madrid Spain
Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada
Department of Biostatistics Harvard T H Chan School of Public Health Boston Massachusetts
Department of Clinical Sciences Faculty of Medicine University of Barcelona Barcelona Spain
Department of Epidemiology Harvard T H Chan School of Public Health Boston Massachusetts
Department of Epidemiology University of Washington School of Public Health Seattle Washington
Department of Medicine Memorial Sloan Kettering Cancer Center New York New York
Department of Medicine Weill Cornell Medical College New York New York
Department of Nutrition Harvard T H Chan School of Public Health Boston Massachusetts
Digestive Diseases and Microbiota Group Girona Biomedical Research Institute Salt Girona Spain
Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany
Genetic Medicine and Family Clinic The Royal Melbourne Hospital Parkville Victoria Australia
Medical Research Council Integrative Epidemiology Unit University of Bristol Bristol United Kingdom
Public Health Sciences Division Fred Hutchinson Cancer Center Seattle Washington
University Cancer Center Hamburg Medical Center Hamburg Eppendorf Hamburg Germany
See more in PubMed
Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology 2020;158:322–340. PubMed PMC
Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nature Medicine 2019;25:667–678. PubMed PMC
Chen HM, Yu YN, Wang JL, Lin YW, Kong X, Yang CQ, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. American Journal of Clinical Nutrition 2013;97:1044–1052. PubMed
Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nature Genetics 2019;51:600–605. PubMed PMC
Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, et al. Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. JNCI: Journal of the National Cancer Institute 2022;114:740–752. PubMed PMC
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nature Genetics 2019;51:76–87. PubMed PMC
Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, et al. Statistical methods for studying disease subtype heterogeneity. Statistics in Medicine 2016;35:782–800. PubMed PMC
Sze MA, Topçuoğlu BD, Lesniak NA, Ruffin MT, Schloss PD, Fraser CM. Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure. mBio 2019;10:e01454–01419. PubMed PMC